{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:34:45Z","timestamp":1759937685290},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T00:00:00Z","timestamp":1470096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s12020-016-1044-0","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T06:06:02Z","timestamp":1470117962000},"page":"379-387","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation"],"prefix":"10.1007","volume":"56","author":[{"given":"Esther Diana","family":"Rossi","sequence":"first","affiliation":[]},{"given":"Tommaso","family":"Bizzarro","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Granja","sequence":"additional","affiliation":[]},{"given":"Maurizio","family":"Martini","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Capodimonti","sequence":"additional","affiliation":[]},{"given":"Emilia","family":"Luca","sequence":"additional","affiliation":[]},{"given":"Guido","family":"Fadda","sequence":"additional","affiliation":[]},{"given":"Celestino Pio","family":"Lombardi","sequence":"additional","affiliation":[]},{"given":"Alfredo","family":"Pontecorvi","sequence":"additional","affiliation":[]},{"given":"Luigi Maria","family":"Larocca","sequence":"additional","affiliation":[]},{"given":"Fatima","family":"Baltazar","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Schmitt","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,8,2]]},"reference":[{"key":"1044_CR1","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1210\/er.2007-0007","volume":"28","author":"M Xing","year":"2007","unstructured":"M. Xing, BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases and clinical implications. Endocr. Rev. 28, 742\u2013762 (2007)","journal-title":"Endocr. Rev."},{"key":"1044_CR2","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/cncr.26500","volume":"118","author":"TH Kim","year":"2012","unstructured":"T.H. Kim, Y.J. Park, J.A. Lim, H.Y. Ahn et al., The association of the BRAF V600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer. Cancer 118, 1764\u20131773 (2012)","journal-title":"Cancer"},{"key":"1044_CR3","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1089\/thy.2009.0240","volume":"19","author":"MN Nikiforova","year":"2009","unstructured":"M.N. Nikiforova, Y. Nikiforov, Molecular diagnostics and predictors in thyroid cancer. Thyroid 19, 1351\u20131361 (2009)","journal-title":"Thyroid"},{"key":"1044_CR4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.5858\/2010-0664-RAIR.1","volume":"135","author":"YE Nikiforov","year":"2011","unstructured":"Y.E. Nikiforov, Molecular diagnostics of thyroid tumors. Arch. Pathol. Lab. Med. 135, 569\u2013577 (2011)","journal-title":"Arch. Pathol. Lab. Med."},{"key":"1044_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/path.1511","volume":"202","author":"V Trovisco","year":"2004","unstructured":"V. Trovisco, I. Vieira de Castro, P. Soares et al., BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J. Pathol. 202, 247\u2013251 (2004)","journal-title":"J. Pathol."},{"key":"1044_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1159\/000363439","volume":"58","author":"ED Rossi","year":"2014","unstructured":"E.D. Rossi, G. Fadda, F. Schmitt, The night mare of indeterminate follicular proliferations: When liquid based cytology and ancillary techniques area not a moon landing but a concrete plan. Acta Cytol. 58, 543\u2013551 (2014)","journal-title":"Acta Cytol."},{"key":"1044_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.7156\/najms.2012.054212","volume":"5","author":"H Chen","year":"2012","unstructured":"H. Chen, I. Izevbaye, F. Chen, B. Weinstein, Recent advances in follicular variant of papillary thyroid carcinoma. N. A. J. Med. Sci. 5, 212\u2013219 (2012)","journal-title":"N. A. J. Med. Sci."},{"key":"1044_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/eci.12577","volume":"46","author":"Z Wang","year":"2016","unstructured":"Z. Wang, J.Q. Chen, J.L. Liu, X.G. Qin, Clinical impact of BRAF mutation in the diagnosis and prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis. Eur. J. Clin. Invest. 46, 146\u2013157 (2016)","journal-title":"Eur. J. Clin. Invest."},{"key":"1044_CR9","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1016\/j.humpath.2013.06.018","volume":"44","author":"CA Routhier","year":"2013","unstructured":"C.A. Routhier, M.C. Mochel, K. Lynch, D. Dias-Santagata, D.N. Louis, M.P. Hoang, Comparison of 2monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma and gliomas. Human Pathol. 44, 2563\u20132570 (2013)","journal-title":"Human Pathol."},{"key":"1044_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/cncy.21352","volume":"122","author":"AK Zimmermann","year":"2014","unstructured":"A.K. Zimmermann, U. Camerisch, M.P. Rechsteiner, B. Bode-Lesniewska, M. Rossle, Value of immunohistochemistry in detection of BRAF V600E mutations in fine needle aspiration biopsies of papillary thyroid carcinoma. Cancer Cytopathol 122, 48\u201358 (2014)","journal-title":"Cancer Cytopathol"},{"key":"1044_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/cncy.21416","volume":"122","author":"ED Rossi","year":"2014","unstructured":"E.D. Rossi, M. Martini, S. Capodimonti, B. Angrisani et al., Analysis of immunocytochemistry and molecular BRAF expression in thyroid carcinoma: Cyto-histological institutional experience. Cancer Cytopathol. 122, 527\u2013535 (2014)","journal-title":"Cancer Cytopathol."},{"key":"1044_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00428-014-1552-3","volume":"464","author":"RK Virk","year":"2014","unstructured":"R.K. Virk, C.G.A. Theoharis, A. Prasad, D. Chhieng, M.L. Prasad, Morphology predicts BRAFR V600E mutation in papillary thyroid carcinoma: an interobserver reproducibility study. Virchow Arch 464, 435\u2013442 (2014)","journal-title":"Virchow Arch"},{"key":"1044_CR13","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/j.1365-2559.2011.04149.x","volume":"60","author":"A Finkelstein","year":"2012","unstructured":"A. Finkelstein, G.H. Levy, P. Hui et al., Papillary thyroid carcinomas with and without BRAF V600E mutations are morphological distinct. Histopathology 60, 1052\u20131059 (2012)","journal-title":"Histopathology"},{"key":"1044_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/cncy.21475","volume":"122","author":"ED Rossi","year":"2014","unstructured":"E.D. Rossi, T. Bizzarro, M. Martini et al., Morphologic parameters able to predict BRAF V600E mutated malignancies on thyroid FNAC. Our institutional experience. Cancer Cytopathol. 122, 883\u2013891 (2014)","journal-title":"Cancer Cytopathol."},{"key":"1044_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00428-014-1607-5","volume":"465","author":"ED Rossi","year":"2014","unstructured":"E.D. Rossi, T. Bizzarro, G. Fadda, L.M. Larocca, F.S. Schmitt, Is morphology alone able to predict BRAF mutated malignancies on thyroid FNAC? Virchows Arch 465, 247\u2013248 (2014)","journal-title":"Virchows Arch"},{"key":"1044_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ccr.2010.10.029","volume":"19","author":"I Arozarena","year":"2011","unstructured":"I. Arozarena, B. Sanchez-Laorden, L. Packer, C. Hidalgo-Carcedo et al., Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A. Cancer Cell 19, 45\u201357 (2011)","journal-title":"Cancer Cell"},{"key":"1044_CR17","doi-asserted-by":"publisher","first-page":"584","DOI":"10.18632\/oncotarget.965","volume":"4","author":"A Hall","year":"2013","unstructured":"A. Hall, K.D. Meyle, M.K. Lange et al., Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600E BRAF oncogene. Oncotarget 4, 584\u2013599 (2013)","journal-title":"Oncotarget"},{"key":"1044_CR18","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1210\/jc.2010-1071","volume":"96","author":"MH Lee","year":"2011","unstructured":"M.H. Lee, S.E. Lee, D.W. Kim et al., Mitochondrial localization and regulation of BRAF V600E in thyroid cancer: a clinically used RAF inhibitor is unable to block the mitochondrial activities of BRAF V600E . J. Clin. Endocrinol. Metab. 96, E19\u2013E30 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1044_CR19","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1101\/gad.228122.113","volume":"27","author":"E White","year":"2015","unstructured":"E. White, Exploiting the bad eating habits of RAS-driven cancers. Genes and Develop. 27, 2065\u20132071 (2015)","journal-title":"Genes and Develop."},{"key":"1044_CR20","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1158\/2159-8290.CD-14-0196","volume":"4","author":"AM Strohecker","year":"2014","unstructured":"A.M. Strohecker, E. White, Targeting mitochondrial metabolism by inhibiting autophagy in BRAF-driven cancers. Cancer Discov. 4, 766\u2013772 (2014)","journal-title":"Cancer Discov."},{"key":"1044_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1479-5876-12-118","volume":"12","author":"C Pinheiro","year":"2014","unstructured":"C. Pinheiro, V. Penna, F. Morais-Santos et al., Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas:distinct prognostic impact of MCT1 subcellular localization. J. Transl. Med. 12, 118\u2013128 (2014)","journal-title":"J. Transl. Med."},{"key":"1044_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00428-007-0558-5","volume":"452","author":"C Pinheiro","year":"2008","unstructured":"C. Pinheiro, A. Longatto-Filho, C. Scapulatempo et al., Increased expression of monocarboxylate transporters 1,2 and 4 in colorectal carcinomas. Virchows Arch 452, 139\u2013146 (2008)","journal-title":"Virchows Arch"},{"key":"1044_CR23","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1016\/j.ejca.2009.06.018","volume":"45","author":"C Pinheiro","year":"2009","unstructured":"C. Pinheiro, A. Longatto-Filho, K. Simoes et al., The prognostic value of CD147\/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer. Eur. J. Cancer 45, 2418\u20132424 (2009)","journal-title":"Eur. J. Cancer"},{"key":"1044_CR24","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1365-2559.2010.03560.x","volume":"56","author":"C Pinheiro","year":"2010","unstructured":"C. Pinheiro, A. Albergaria, J. Paredes et al., Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 56, 860\u2013867 (2010)","journal-title":"Histopathology"},{"key":"1044_CR25","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/dc.22821","volume":"40","author":"C Pinheiro","year":"2012","unstructured":"C. Pinheiro, A. Longatto-Filho, T. Soares et al., CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma. Diagn. Cytopathol. 40, 478\u2013483 (2012)","journal-title":"Diagn. Cytopathol."},{"key":"1044_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1155\/2009\/169678","volume":"26","author":"C Pinheiro","year":"2009","unstructured":"C. Pinheiro, A. Longatto-Filho, S.M.M. Pereira et al., Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma. Dis. Markers 26, 97\u2013103 (2009)","journal-title":"Dis. Markers"},{"key":"1044_CR27","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1248\/bpb.33.1568","volume":"33","author":"K Narumi","year":"2010","unstructured":"K. Narumi, A. Furugen, M. Kobayashi, S. Otake, S. Itagaki, K. Iseki, Regulation of monocarboxylate transporter 1 in skeletal muscle cells by intracellular signaling pathways. Biol. Pharm. Bull. 33, 1568\u20131573 (2010)","journal-title":"Biol. Pharm. Bull."},{"key":"1044_CR28","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1530\/EJE-13-0023","volume":"168","author":"ED Rossi","year":"2013","unstructured":"E.D. Rossi, M. Martini, S. Capodimonti et al., Diagnostic and prognostic value of immunocytochemistry and BRAF mutation analysis on liquid based biopsies of thyroid neoplasms suspicious for carcinoma. Eur. J. Endocrinol. 168, 853\u2013859 (2013)","journal-title":"Eur. J. Endocrinol."},{"key":"1044_CR29","unstructured":"British Thyroid Association, Guidelines for the Management of Thyroid Cancer, 2nd edn. London (2007)"},{"key":"1044_CR30","first-page":"405","volume":"102","author":"G Fadda","year":"2010","unstructured":"G. Fadda, F. Basolo, A. Bondi et al.; SIAPEC-IAP Italian Consensus Working Group, Cytological classification of thyroid nodules. Pathologica 102, 405\u2013408 (2010)","journal-title":"Pathologica"},{"key":"1044_CR31","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1089\/thy.2009.0274","volume":"19","author":"ES Cibas","year":"2009","unstructured":"E.S. Cibas, S.Z. Ali, The Bethesda system for reporting thyroid cytopathology. Thyroid 19, 1159\u20131165 (2009)","journal-title":"Thyroid"},{"key":"1044_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/cncy.21258","volume":"121","author":"ED Rossi","year":"2013","unstructured":"E.D. Rossi, M. Martini, S. Capodimonti, C.P. Lombardi et al., BRAF(V600E) mutation analysis on LBC-processed aspiration biopsies predicts bilaterality and nodal involvement in papillary thyroid microcarcinoma. Cancer Cytopathol. 121, 291\u2013297 (2013)","journal-title":"Cancer Cytopathol."},{"key":"1044_CR33","unstructured":"American Joint Commission on Cancer (AJCC), Cancer Staging Atlas 2nd edn. Chicago (2013)"},{"key":"1044_CR34","first-page":"77","volume":"6191","author":"F Morais-Santos","year":"2015","unstructured":"F. Morais-Santos, S. Granja, Miranda-Gon\u00e7alves V et al., Targeting lactate transport suppresses in vivo breast tumour growth. Oncotarget 6191, 77\u201389 (2015)","journal-title":"Oncotarget"},{"key":"1044_CR35","doi-asserted-by":"publisher","first-page":"6708","DOI":"10.18632\/oncotarget.2862","volume":"6","author":"S Granja","year":"2015","unstructured":"S. Granja, I. Marchiq, R. Le Floch, C.S. Moura, F. Baltazar, J. Pouyss\u00e9gur, Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1. Oncotarget 6, 6708\u20136721 (2015)","journal-title":"Oncotarget"},{"key":"1044_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10863-012-9428-1","volume":"44","author":"C Pinheiro","year":"2012","unstructured":"C. Pinheiro, A. Longatto-Filho, J. Azevedo-Silva, M. Casal, F.C. Schmitt, F. Baltazar, Role of monocarboxylate transporters in human cancers:state of the art. J. Bioenerg. Biomembr. 44, 127\u2013139 (2012)","journal-title":"J. Bioenerg. Biomembr."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1044-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-1044-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1044-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1044-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T18:13:18Z","timestamp":1656958398000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-1044-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-1044-0","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,2]]},"assertion":[{"value":"22 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}